JD.com, Inc. (NASDAQ:JD – Get Free Report) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 34,520,000 shares, a decline of 8.0% from the May 31st total of 37,520,000 shares. Based on an average daily volume of 12,250,000 shares, the short-interest ratio is presently 2.8 days.
Institutional Trading of JD.com
Institutional investors have recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC raised its position in shares of JD.com by 812.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,888 shares of the information services provider’s stock valued at $52,000 after purchasing an additional 1,681 shares during the period. Hexagon Capital Partners LLC bought a new position in JD.com during the first quarter worth $58,000. CWM LLC increased its position in JD.com by 69.3% during the fourth quarter. CWM LLC now owns 2,952 shares of the information services provider’s stock worth $85,000 after acquiring an additional 1,208 shares during the period. Compagnie Lombard Odier SCmA increased its position in JD.com by 73.5% during the fourth quarter. Compagnie Lombard Odier SCmA now owns 3,850 shares of the information services provider’s stock worth $111,000 after acquiring an additional 1,631 shares during the period. Finally, Parallel Advisors LLC increased its holdings in JD.com by 20.1% in the 4th quarter. Parallel Advisors LLC now owns 4,102 shares of the information services provider’s stock valued at $119,000 after buying an additional 686 shares during the period. 15.98% of the stock is currently owned by institutional investors and hedge funds.
JD.com Price Performance
NASDAQ JD opened at $26.09 on Wednesday. The company has a quick ratio of 0.88, a current ratio of 1.15 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $41.15 billion, a PE ratio of 11.91 and a beta of 0.39. The company has a 50 day moving average price of $30.27 and a two-hundred day moving average price of $27.01. JD.com has a 12-month low of $20.82 and a 12-month high of $41.95.
Analysts Set New Price Targets
JD has been the topic of several recent research reports. Barclays lifted their price objective on shares of JD.com from $39.00 to $41.00 and gave the stock an “overweight” rating in a research note on Friday, May 17th. Morgan Stanley reissued an “equal weight” rating and issued a $27.00 target price on shares of JD.com in a research report on Thursday, April 18th. Benchmark reissued a “buy” rating and issued a $55.00 target price on shares of JD.com in a research report on Friday, May 17th. StockNews.com downgraded shares of JD.com from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, JPMorgan Chase & Co. lifted their target price on shares of JD.com from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Friday, April 5th. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $37.20.
Read Our Latest Stock Report on JD.com
JD.com Company Profile
JD.com, Inc operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry.
Read More
- Five stocks we like better than JD.com
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- RXO Shares Surge Following New Acquisition Deal
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for JD.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JD.com and related companies with MarketBeat.com's FREE daily email newsletter.